SCHEMBL9205677

SCHEMBL9205677

Cc1occc1C(=O)Nc1ccc(Cl)c(C(=O)OC(C)C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 10/20 0.57
RAB9A P51151 9/20 0.57
NPC1 O15118 8/20 0.57
PKM P14618 4/20 0.57
POLB P06746 2/20 0.57
ALDH1A1 P00352 7/20 0.57
LMNA P02545 4/20 0.57
TP53 P04637 4/20 0.54
HSD17B10 Q99714 3/20 0.54
USP2 O75604 1/20 0.54
ALOX15 P16050 1/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
HTT P42858 4/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HPGD P15428 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
STAT1 P42224 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203140 0.90 LMNA (0.48) SMN1; SMN2RAB9ANPC1PKMPOLB
SCHEMBL29450678 0.90 LMNA (0.48) SMN1; SMN2RAB9ANPC1PKMPOLB
SCHEMBL9203674 0.85 GRM1 (0.53) SMN1; SMN2RAB9ANPC1PKMMEN1
SCHEMBL27522241 0.84 SMN1; SMN2 (0.64) SMN1; SMN2RAB9ANPC1PKMPOLB
SCHEMBL9199828 0.83 AKR1C3 (0.56) SMN1; SMN2RAB9ANPC1PKMPOLB
SCHEMBL9201214 0.81 NPC1 (0.54) SMN1; SMN2RAB9ANPC1POLBALDH1A1
SCHEMBL27309634 0.81 RAB9A (0.66) SMN1; SMN2RAB9ANPC1PKMALDH1A1
SCHEMBL29631543 0.81 LMNA (0.44) SMN1; SMN2RAB9ANPC1PKMPOLB
SCHEMBL8930039 0.81 DHODH (0.56) SMN1; SMN2RAB9ANPC1PKMPOLB
SCHEMBL9199855 0.80 KMT2A (0.50) SMN1; SMN2RAB9ANPC1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP claimed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP claimed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO claimed
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP disclosed
US-5268389-A Containing a benzene ring UNIROYAL CHEMICAL COMPANY, INC. (US) 1993-12-07 US disclosed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP disclosed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO disclosed